Searched for
SALIX
Lupin gets FDA nod to market ulcerative colitis tablets in USThe company has received tentative approval to market its Balasalazide Disodium tablets 1.1 gm from the United States Food and Drug Adminis...29 Dec, 2016, 03.43 PM IST- Lupin launches anti-bacterial Zaxine tablets in CanadaZaxine 550 mg (rifaximin) is a long-term antibiotic treatment drug for adults living with HE, a complication of liver disease (cirrhosis).20 Apr, 2015, 02.33 PM IST
- Continuously evaluating opportunities for tie-ups with large MNCs: Ramesh Swaminathan, Lupin'We do keep talking to various big pharma companies for various kinds of alliance. So potentially I cannot speak about any deal until it ac...15 Sep, 2014, 03.58 PM IST
- What does Crofelemer approval mean for Glenmark?What does Crofelemer approval mean for Glenmark?03 Jan, 2013, 06.06 PM IST
- Glenmark US partner Salix gets USFDA nod for Crofelemer tabletUS Food and Drug Administration provided marketing approval to its partner in US, Salix Pharmaceuticals, for Crofelemer 125 mg delayed-rele...02 Jan, 2013, 02.09 PM IST
- Crofelemer approval a big positive for company: Glenn Saldanha, Glenmark Pharma"There is another $6 million that Salix is likely to pay us for the facility that we are working on for the supplies of Crofelemer."02 Jan, 2013, 12.24 PM IST
- USFDA approves Glenmark’s anti-diarrheal drug; stock gainsShares of Glenmark Pharma gained momentum following the FDA approval to Salix Pharma for marketing Crofelemer.01 Jan, 2013, 12.43 PM IST
- Glenmark Pharmaceuticals to initiate filing for Crofelemer as Salix submits NDAGlenmark is going full steam ahead with the launch of Crofelemer post the issue of Napo Pharma's claim of termination of the deal.16 Dec, 2011, 08.21 AM IST
- Napo termination will not impact company: GlenmarkIn an interview with ET Now, Glenn Saldanha, Chairman and Managing Director, Glenmark, gives his views on the company's strategies. Excerpt...15 Dec, 2011, 01.42 PM IST
- Glenmark files arbitration claim against Napo PharmaceuticalsGlenmark has filed arbitration claims against Napo Pharmaceuticals for ending a contract to develop and market diarrhea drug.14 Dec, 2011, 04.07 AM IST
- We anticipate margins between 22% to 23% for the full year: Glenn Saldanha, Glenmark Ltd.Glenn Saldanha, Chairman and Managing Director, Glenmark Ltd., in an interview with ET Now, speaks about the company’s performance in the q...26 Jul, 2011, 03.44 PM IST
- Glenmark gets $15 mn plant upgradation advance from SalixGlenmark Pharmaceuticals on Tuesday said it has received USD 15 million (over Rs 65 crore) from Salix Pharmaceuticals Inc, USA.26 Jul, 2011, 12.43 PM IST
- Lupin settles patent suit over Solodyn tablets with Medicis, signs R&D agreementDrug maker Lupin said it has settled patent suit with Medicis Pharmaceutical and signed a pact for development of multiple therapeutic comp...25 Jul, 2011, 05.20 PM IST
- Glenmark achieves positive results for anti-diarrhoea moleculeGlenmark and Salix have also entered into a commercial supply agreement for Crofelemer active pharmaceutical ingredient.08 Feb, 2011, 03.35 AM IST
- Glenmark Pharma: Miles to go before new drug makes a markGlenmark’s partners — US-based Napo Pharmaceuticals and Salix Pharmaceuticals — have announced completion of phase-III trials for the drug ...09 Nov, 2010, 01.58 AM IST
- Glenmark moves closer to HIV drug launchGlenmark Pharmaceuticals has completed the third phase of human trials of Crofelemer, a new drug to treat HIV-related diarrhoea that could ...09 Nov, 2010, 01.51 AM IST
- Glenmark will launch Crofelemer in ROW countries by 2010Glenmark Pharmaceuticals Ltd has reported new development that should accelerate the launch of Crofelemer.22 Dec, 2008, 01.19 PM IST
Load More
